![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2024
Scheubeck, Gabriel 
ORCID: https://orcid.org/0009-0004-2546-6154; Hoffmann, Martin; Jurinovic, Vindi; Fischer, Luca ORCID: https://orcid.org/0000-0003-2444-416X; Unterhalt, Michael; Schmidt, Christian; Böck, Hans-Peter; Dührsen, Ulrich; Kaesberger, Joachim; Kremers, Stephan; Lindemann, Hans-Walter; Mantovani, Luisa; Hiddemann, Wolfgang; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389 und Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249
(2024):
Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma: results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study Group.
In: Annals of Hematology, Bd. 103: S. 2373-2380
[PDF, 1MB]
ORCID: https://orcid.org/0009-0004-2546-6154; Hoffmann, Martin; Jurinovic, Vindi; Fischer, Luca ORCID: https://orcid.org/0000-0003-2444-416X; Unterhalt, Michael; Schmidt, Christian; Böck, Hans-Peter; Dührsen, Ulrich; Kaesberger, Joachim; Kremers, Stephan; Lindemann, Hans-Walter; Mantovani, Luisa; Hiddemann, Wolfgang; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389 und Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249
(2024):
Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma: results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study Group.
In: Annals of Hematology, Bd. 103: S. 2373-2380
[PDF, 1MB]
2018
Lengfelder, Eva; Goerlich, Dennis; Nowak, Daniel; Spiekermann, Karsten; Haferlach, Claudia; Krug, Utz; Kreuzer, Karl-Anton; Braess, Jan; Schliemann, Christoph; Lindemann, Hans-Walter; Horst, Heinz A.; Schiel, Xaver; Flasshove, Michael; Hecht, Anna; Schnittger, Susanne; Schneider, Stephanie; Wörmann, Bernhard; Hofmann, Wolf-Karsten; Berdel, Wolfgang E.; Bormann, Eike; Sauerland, Cristina; Büchner, Thomas und Hiddemann, Wolfgang
(2018):
Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines.
In: European Journal of Haematology, Bd. 100, Nr. 2: S. 154-162